« The U.S. Military Academy declares war on Internet scammers |
Main
| The Data and Information Guru »
August 23, 2005
OSI Pharmaceuticals to acquire Eyetech
Posted by Dominic Basulto

Long Island-based OSI Pharmaceuticals will acquire Eyetech Pharmaceuticals, which has offices in Times Square, for approximately $935 million in stock and cash. OSI Pharmaceuticals specializes in cancer treatments while Eyetech makes the age-related macular degeneration treatment Macugen. According to the terms of the deal, OSI will pay $20 per share for Eyetech, a 43% premium to the stock's closing price of $13.99 on Friday.
Comments (0)
+ TrackBacks (0) | Category: Deals
- RELATED ENTRIES
- East Village bar up for sale on eBay
- Eliot Spitzer takes on the national cinema chains
- California winemakers to sell wine to New Yorkers via the Internet
- A blogger could become "Media Person of the Year"
- A la carte cable TV pricing
- NYSIA Incubator launch party tonight
- Why the mathematics of congestion pricing don't work
- Enjoy the holiday shopping bargains at Century 21 while you can
TrackBack URL:
http://www.corante.com/cgi-bin/mt/external.cgi/31633